close read more

The Servier Group

Committed to therapeutic progress to serve patient needs

Meet the healthcare challenges of tomorrow

Committed employees

Men and women proud to contribute to care for patients and save lives

Join our Group

Servier R&D

Meeting patient needs as effectively as possible

Accelerate therapeutic innovation

A local production

The agility of an integrated industrial model

Industrial excellence for a quality healthcare offering

Servier - Independent international pharmaceutical laboratory

logo twitter


countries in which
the Group’s medicines
are distributed
23 %

of revenue from brand-name medicines invested in R&D in 2019/2020.

4.7 billion

euros in revenue in 2019/2020 comprising €3.3 billion for brand-name medicines and €1.4 billion for generic medicines.

4 therapeutic areas

cardiometabolism, neuroscience
and immuno-inflammation

icon play
icon play

Join our teams!

We do everything possible for all Group employees to have the means to succeed, to adapt, to take on responsibilities and to grow. At Servier, you will be offered a unique and meaningful professional experience.

Oril Industrie, Servier’s centre of excellence in chemistry for the past 60 years!

Servier had always been committed to independence in the health sector, having always chosen to maintain production capacities in Europe and more specifically in France.

icon play


Did you know that 463 million people are affected by diabetes worldwide?
To help you better understand diabetes, watch the discussion between our two experts:
Prof. João Filipe Raposo, Clinical Director at APDP – Portuguese Diabetes Association, and Dr. Bertrand Renaud, Chief Patient Officer at Servier.

The basis for our actions

Because passing on to future generations a world that can ensure access to quality health care for all is our vision for the future, at Servier, all over the world, we are ready to meet the health care challenges of tomorrow, for and with patients. Discover our corporate video.

icon play